AtriCure (ATRC) EPS (Weighted Average and Diluted) (2019 - 2026)
AtriCure (ATRC) reported EPS (Weighted Average and Diluted) of $0.0 for Q1 2026, up 101.57% year-over-year from $0.0 in Q1 2025, and down 94.49% quarter-over-quarter from $0.04 in Q4 2025.
AtriCure (ATRC) EPS (Weighted Average and Diluted) (2019 - 2026) Analysis & Trends
AtriCure (ATRC) has 8 years of EPS (Weighted Average and Diluted) data on file, last reported at $0.0 in Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at $0.0, up 101.57% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.1 (up 87.65% YoY), and the FY2025 annual result was -$0.24, up 74.74% from the prior year.
- EPS (Weighted Average and Diluted) slipped to $0.0 in Q1 2026 per ATRC's latest filing, from $0.04 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $0.04 in Q4 2025 and troughed at -$0.33 in Q1 2022.
- A 5-year average of -$0.17 and a median of -$0.17 in 2024 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2023 and 2025: EPS (Weighted Average and Diluted) tumbled 133.33% in 2023, then surged 112.12% in 2025.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.09 in 2022, then plunged by 133.33% to -$0.21 in 2023, then sank by 57.14% to -$0.33 in 2024, then jumped by 112.12% to $0.04 in 2025, then slumped by 94.49% to $0.0 in 2026.
- Business Quant data shows ATRC's EPS (Weighted Average and Diluted) at $0.0 in Q1 2026, $0.04 in Q4 2025, and -$0.01 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 2.28 |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -1.11 |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 0.16 |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 2.74 |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 1.92 |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 0.07 |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -0.40 |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.57 |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -0.03 |
| 10 | AtriCure | 1.34 Bn | 1.19 Bn | 109.31 Mn | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 0.04 |
| Sep 30, 2025 | -0.01 |
| Jun 30, 2025 | -0.13 |
| Mar 31, 2025 | -0.14 |
| Dec 31, 2024 | -0.33 |
| Sep 30, 2024 | -0.17 |
| Jun 30, 2024 | -0.17 |
| Mar 31, 2024 | -0.28 |
| Dec 31, 2023 | -0.21 |
| Sep 30, 2023 | -0.20 |
| Jun 30, 2023 | -0.11 |
| Mar 31, 2023 | -0.14 |
| Dec 31, 2022 | -0.09 |
| Sep 30, 2022 | -0.27 |
| Jun 30, 2022 | -0.32 |
| Mar 31, 2022 | -0.33 |
| Dec 31, 2021 | -0.30 |
| Sep 30, 2021 | 2.11 |
| Jun 30, 2021 | -0.36 |